Clinical Trial Update: Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX [Phase 2]

View source ↗

Summary

Phase 2 trial update for Megestrol Acetate oral suspension to manage cancer cachexia in patients with stage III gastric cancer or gastroesophageal junction aden…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• Serplulimab (serplulimab)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Stage III Gastric Cancer | Phase 2 | Status: NOT_YET_RECRUITING